Sophia Masi1, Naveen Chennamaneni1, Frantisek Turecek1, C Ronald Scott2, Michael H Gelb3. 1. Department of Chemistry, University of Washington, Seattle, WA. 2. Department of Pediatrics, University of Washington, Seattle, WA. 3. Department of Chemistry, University of Washington, Seattle, WA; gelb@uw.edu.
Abstract
BACKGROUND: Deficiency of lysosomal acid lipase (LAL) causes Wolman disease and cholesterol ester storage disease. With the recent introduction of enzyme replacement therapy to manage LAL deficiency comes the need for a reliable assay of LAL enzymatic activity that can be applied to dried blood spots (DBS). METHODS: We prepared and tested a library of analogs of palmitoyl 4-methylumbelifferyl esters to find a highly active and specific substrate for LAL in DBS. The LAL assay was optimized leading to both LC-MS/MS and fluorometric assay of LAL. We tested the new assay on DBS from healthy and LAL-deficient patients. RESULTS: The ester formed between palmitic acid and 4-propyl-8-methyl-7-hydroxycoumarin (P-PMHC) was found to be >98% selective for LAL in DBS based on the sensitivity of its activity to the LAL-specific inactivator Lalistat-2 and the fact that the activity was close to zero using DBS from patients previously shown to be LAL-deficient. Use of P-PMHC and heavy isotope-labeled internal standard with optimized assay conditions led to an approximately 2-fold increase in the specific activity of LAL compared with the previously reported LAL assay. Patients deficient in LAL were readily distinguished from normal persons with the new LAL assay using UPLC-MS/MS or fluorometric assay platforms. CONCLUSIONS: The new assay can measure LAL in DBS with a single measurement compared with the previous method involving 2 assays done in parallel.
BACKGROUND:Deficiency of lysosomal acid lipase (LAL) causes Wolman disease and cholesterol ester storage disease. With the recent introduction of enzyme replacement therapy to manage LAL deficiency comes the need for a reliable assay of LAL enzymatic activity that can be applied to dried blood spots (DBS). METHODS: We prepared and tested a library of analogs of palmitoyl 4-methylumbelifferyl esters to find a highly active and specific substrate for LAL in DBS. The LAL assay was optimized leading to both LC-MS/MS and fluorometric assay of LAL. We tested the new assay on DBS from healthy and LAL-deficientpatients. RESULTS: The ester formed between palmitic acid and 4-propyl-8-methyl-7-hydroxycoumarin (P-PMHC) was found to be >98% selective for LAL in DBS based on the sensitivity of its activity to the LAL-specific inactivator Lalistat-2 and the fact that the activity was close to zero using DBS from patients previously shown to be LAL-deficient. Use of P-PMHC and heavy isotope-labeled internal standard with optimized assay conditions led to an approximately 2-fold increase in the specific activity of LAL compared with the previously reported LAL assay. Patients deficient in LAL were readily distinguished from normal persons with the new LAL assay using UPLC-MS/MS or fluorometric assay platforms. CONCLUSIONS: The new assay can measure LAL in DBS with a single measurement compared with the previous method involving 2 assays done in parallel.
Authors: Yijun Li; C Ronald Scott; Nestor A Chamoles; Ahmad Ghavami; B Mario Pinto; Frantisek Turecek; Michael H Gelb Journal: Clin Chem Date: 2004-08-03 Impact factor: 8.327
Authors: Brian J Wolfe; Sophie Blanchard; Martin Sadilek; C Ronald Scott; Frantisek Turecek; Michael H Gelb Journal: Anal Chem Date: 2010-12-30 Impact factor: 6.986
Authors: Francis Rajamohan; Allan R Reyes; Wanida Ruangsiriluk; Lise R Hoth; Seungil Han; Nicole Caspers; Meihua Tu; Jessica Ward; Ravi G Kurumbail Journal: Protein Expr Purif Date: 2015-01-22 Impact factor: 1.650
Authors: Simon A Jones; Sandra Rojas-Caro; Anthony G Quinn; Mark Friedman; Sachin Marulkar; Fatih Ezgu; Osama Zaki; J Jay Gargus; Joanne Hughes; Dominique Plantaz; Roshni Vara; Stephen Eckert; Jean-Baptiste Arnoux; Anais Brassier; Kim-Hanh Le Quan Sang; Vassili Valayannopoulos Journal: Orphanet J Rare Dis Date: 2017-02-08 Impact factor: 4.123
Authors: Susan Elliott; Norman Buroker; Jason J Cournoyer; Anna M Potier; Joseph D Trometer; Carole Elbin; Mack J Schermer; Jaana Kantola; Aaron Boyce; Frantisek Turecek; Michael H Gelb; C Ronald Scott Journal: Mol Genet Metab Date: 2016-05-20 Impact factor: 4.797
Authors: Ron C Helderman; Daniel G Whitney; Madalina Duta-Mare; Alena Akhmetshina; Nemanja Vujic; Shobana Jayapalan; Jeffry S Nyman; Biswapriya B Misra; Clifford J Rosen; Michael P Czech; Dagmar Kratky; Elizabeth Rendina-Ruedy Journal: Bone Date: 2021-04-07 Impact factor: 4.626
Authors: Nikolay Mayanskiy; Ekaterina Brzhozovskaya; Alexander Pushkov; Tatiana Strokova; Nikolay Vlasov; Andrej Surkov; Olga Gundobina; Kirill Savostianov Journal: JIMD Rep Date: 2019-06-03
Authors: Joseph J Shen; Jessica L Davis; Xinying Hong; Fred H Laningham; Michael H Gelb; Grace E Kim Journal: J Pediatr Gastroenterol Nutr Date: 2020-12 Impact factor: 3.288